tiprankstipranks
Lexington Biosciences (LXGTF)
:LXGTF
US Market

Lexington Biosciences (LXGTF) Income Statement

Compare
8 Followers

Lexington Biosciences Income Statement

Last quarter (Q2 2024), Lexington Biosciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Lexington Biosciences's net income was C$-42.77K. See Lexington Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 157.83K---C$ 533.53K
Depreciation and Amortization
C$ 157.83KC$ 173.48KC$ 312.63KC$ 459.50KC$ 489.37K
EBITDA
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Income
C$ -157.83K---C$ -533.53K
Other Income/Expenses
C$ -19.55KC$ -2.49KC$ -11.61KC$ -21.12KC$ -780.41K
Pretax Income
C$ -177.38K---C$ -1.27M
Net Income
----C$ -1.27M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -0.34
Diluted EPS
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ -0.34
Weighted Average Shares Outstanding
17.74M 27.46M 27.46M 12.05M 3.79M
Weighted Average Shares Outstanding (Diluted)
27.46M 27.46M 27.46M 12.05M 3.79M
Currency in CAD

Lexington Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis